HMGB1 and prostate carcinoma: Further, CP1 induced ICD in both mouse and human prostate cancer cells in vitro, as determined by increased HMGB1, ATP, calreticulin, and CXCL10, and in tumor tissue in vivo, as determined by HMGB1 secretion and increased cell surface calreticulin.